Company Filing History:
7 out of 559 
3 out of 3,539 
Years Active: 2020-2024
Title: Prasad S Adusumilli: Innovator in Immunotherapy
Introduction
Prasad S Adusumilli is a prominent inventor based in New York, NY (US), known for his significant contributions to the field of immunotherapy. With a total of 7 patents, he has made remarkable strides in developing innovative treatments for cancer and viral infections.
Latest Patents
Adusumilli's latest patents include groundbreaking work on immune cell compositions and methods of use. One of his notable inventions involves cells that are immune cells or precursor cells that recombinantly express a chimeric antigen receptor (CAR). This CAR binds to a cancer antigen, enhancing the immune response against cancer. Additionally, he has developed T cells that recognize and are sensitized to cancer antigens, which also express a dominant negative form of an inhibitor of a T cell-mediated immune response. Another significant patent focuses on immune cell compositions for treating viral and other infections. This invention involves immune cells that express a dominant negative form of an inhibitor of a cell-mediated immune response and optionally express a CAR that binds to a viral antigen. These advancements provide methods for using such cells to treat viral infections in subjects in need.
Career Highlights
Throughout his career, Adusumilli has worked with esteemed organizations such as Memorial Sloan Kettering Cancer Center and the National Institutes of Health, a component of the US Department of Health & Human Services. His work in these institutions has allowed him to push the boundaries of immunotherapy and contribute to the advancement of medical science.
Collaborations
Adusumilli has collaborated with notable colleagues, including Michel Sadelain and Dimiter Stanchev Dimitrov. These partnerships have fostered innovation and have been instrumental in the development of his patented technologies.
Conclusion
Prasad S Adusumilli's contributions to immunotherapy through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to pave the way for new treatments that can significantly impact patient care.